两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001829126-24-002304 Act: 34 Size: 32 KB 网页链接
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-24-000813 Size: 6 KB 网页链接
$OpGen(OPGN)$ SC 14F1 Statement regarding change in majority of directors [Rule 14f-1] Accession Number: 0001829126-24-002194 Act: 34 Size: 256 KB 网页链接
$OpGen(OPGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000921895-24-000774 Size: 3 KB 网页链接
$OpGen(OPGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000921895-24-000775 Size: 3 KB 网页链接
$OpGen(OPGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000921895-24-000772 Size: 3 KB 网页链接
$OpGen(OPGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000921895-24-000773 Size: 5 KB 网页链接
$OpGen(OPGN)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001829126-24-002093 Act: 34 Size: 53 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.02, 5.03, 8.01, and 9.01 Accession Number: 0001829126-24-002035 Act: 34 Size: 5 MB 网页链接
$OpGen(OPGN)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001829126-24-002011 Act: 34 Size: 21 KB 网页链接